1. Use case review update 10 September 2018 Agenda item 4.0
Presented by Noemi Manent on DD MONTH YYYY
Compliance and Inspection department

2. Agenda Document considerations (MS)
10 September 2018
Agenda
Document considerations (MS)
Consolidate considerations and submit RFI to the sponsor (MS)
Prepare and submit response to RFI (Sponsor)
Use case review update

3. UC 1019 Document considerations
10 September 2018
UC 1019 Document considerations
NOTE: Delete slides from here on before finalising your presentation.
Use case review update

4. Add new consideration
The RMS, MSC or additional MSC selects the considerations form.
The RMS, MSC or additional MSC selects to add a new consideration.
The RMS, MSC or additional MSC populates the considerations fields as per the data specification.
The RMS, MSC or additional MSC saves the populated considerations form.
The RMS, MSC or additional MSC selects the considerations they would like to share with RMS/other MSC.
The RMS, MSC or additional MSC selects to share the consideration with the RMS and all MSC for the clinical trial.
Use case review update

5. UC 1021 consolidate considerations and submit RFI
10 September 2018
UC 1021 consolidate considerations and submit RFI
NOTE: Delete slides from here on before finalising your presentation.
Use case review update

6. Consolidate considerations
The RMS or MSC selects the consolidate considerations form.
The RMS or MSC selects the consideration(s).
The RMS or MSC selects to accept the consideration(s) as per business rules.
The RMS populates the consolidation section of the form to address the considerations that have been shared as per business rule. The MSC can choose to edit the pre-populated consolidation section for the assess part II process.
The RMS or MSC selects to save a draft of the consolidated consideration form.
The RMS selects to share the consolidated considerations with all MSC for the validate application/assess part I processes.
The RMS or MSC selects to create a request for information as per business rules.
The RMS or MSC populates the empty fields in the request for information form as per data specifications.
The RMS or MSC selects to submit the request for information form.
Use case review update

7. UC 1022 prepare and submit response to RFI
10 September 2018
UC 1022 prepare and submit response to RFI
NOTE: Delete slides from here on before finalising your presentation.
Use case review update

8. Prepare and submit response to RFI
The sponsor wants to respond to the RFI submitted by the RMS/MSC and selects the Response to RFI form
The sponsor populates the RFI response form as per the response section in the data specification and where required proceeds to edit the application according to business rule R
The sponsor selects to save the updates to the response to RFI form
The sponsor selects to submit the RFI response form.
The sponsor confirms the submission of updates to the application and the RFI response form
The sponsor confirms the submission of the response to RFI form
The sponsor confirms his agreement with the declaration. Unless this is confirmed the sponsor is unable to proceed with the submission of the response to RFI as per business rule R
Use case review update

9. Use case review update

10. Use case review update

11. Use case review update

12. Use case review update

13. Business rules R01.02.12 R01.02.12 Edit application for RFIID
Name
Description
MOSCOW R
R Edit application for RFI
The applicant shall only be able to submit an updated clinical trial application during the evaluation of the trial in the time allowed by the RFI issued by the MSC requesting additional information.
Must R
R RFI application edits
The entire application will be available to edit when an RFI has been received during the validation process. When an RFI is received for a part I or apart II application only information within those parts of the application can be edited. R
R Agreement Declaration
The applicant must accept the agreement declaration to be able to submit a clinical trial application or a response to an RFI through the EU portal to the Database. R
R Sponsor response documents
When responding to an RFI, only a subsequent version of the document can be uploaded without the ability to delete previous version(s) submitted. R
R Submit additional information timer (B) lapse
If the timer (B) lapses, the status of the Part I application shall be 'Lapsed' in all MSC.
Use case review update

14. Business rules ID
Name
Description
MOSCOW R
R Provide additional information reminder for part I
The Sponsor shall be alerted in the EU portal with 2 days remaining to provide additional information during part I assessment.
Must R
R Provide additional information reminder for part II
The Sponsor shall be alerted in the EU portal with 2 days remaining to provide additional information during part II assessment. R
R Part II timer (B) lapse
If the timer (B) lapses, the status of the Part II application in the applicable MSC shall be 'Lapsed'. R
R Document additional considerations reminder for add MSC
The Sponsor shall be alerted in the EU portal with 5 days and 1 day remaining (timer C) to provide additional information during assessment of an application for an additional MSC. R
R Sponsor to submit additional Part I information timer (C) lapse
If the timer (C) lapses, the application for adding additional member states concerned shall become lapsed in the additional MSC.
Use case review update

15. 10 September 2018

16. Thank you for your attention
10 September 2018
Thank you for your attention
Further information
Please contact me on
European Medicines Agency
30 Churchill Place • Canary Wharf • London E14 5EU • United Kingdom
Telephone +44 (0) Facsimile +44 (0)
Send a question via our website
Note: This slide is OPTIONAL. It uses the 'Closing slide' layout. Delete if not needed.
Follow us on @EMA_News